SPC Financial Inc. Has $606,000 Stake in MetLife, Inc. (NYSE:MET)

SPC Financial Inc. raised its stake in shares of MetLife, Inc. (NYSE:METFree Report) by 6.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,406 shares of the financial services provider’s stock after buying an additional 475 shares during the period. SPC Financial Inc.’s holdings in MetLife were worth $606,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. CX Institutional boosted its stake in shares of MetLife by 15.9% during the 4th quarter. CX Institutional now owns 68,005 shares of the financial services provider’s stock valued at $5,568,000 after buying an additional 9,337 shares during the period. Bank of New York Mellon Corp boosted its stake in shares of MetLife by 109.2% during the 4th quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock valued at $722,727,000 after buying an additional 4,606,748 shares during the period. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in shares of MetLife during the 3rd quarter valued at $2,960,000. Meeder Asset Management Inc. boosted its stake in shares of MetLife by 48,101.4% during the 3rd quarter. Meeder Asset Management Inc. now owns 106,043 shares of the financial services provider’s stock valued at $8,746,000 after buying an additional 105,823 shares during the period. Finally, Segall Bryant & Hamill LLC acquired a new stake in shares of MetLife during the 3rd quarter valued at $1,074,000. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Stock Performance

Shares of MET opened at $83.17 on Thursday. The company has a market capitalization of $56.66 billion, a PE ratio of 13.93, a price-to-earnings-growth ratio of 0.65 and a beta of 1.04. MetLife, Inc. has a one year low of $67.30 and a one year high of $89.05. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. The company’s fifty day moving average price is $83.74 and its 200 day moving average price is $82.15.

MetLife (NYSE:METGet Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. As a group, analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.62%. MetLife’s payout ratio is 36.52%.

Analyst Upgrades and Downgrades

MET has been the subject of a number of research reports. Morgan Stanley lifted their target price on shares of MetLife from $101.00 to $109.00 and gave the company an “overweight” rating in a research note on Friday, February 28th. Barclays reduced their price objective on shares of MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a research note on Friday, February 7th. BMO Capital Markets initiated coverage on shares of MetLife in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price objective for the company. JPMorgan Chase & Co. lifted their price objective on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Finally, TD Cowen lifted their price objective on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. Two research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat.com, MetLife has an average rating of “Moderate Buy” and a consensus price target of $94.58.

Get Our Latest Stock Report on MetLife

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.